Concepedia

Roldano Fossati

RF

30

Publications

7.1K

Citations

25

H-Index

1990

Active since

Affiliations

Mario Negri Institute for Pharmacological Research(Current)

European Institute of Oncology

University of Milano-Bicocca

Azienda Ospedaliera San Gerardo

Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia

Roldano Fossati is an author at Mario Negri Institute for Pharmacological Research specializing in medicine, oncology, and gynecology oncology.

ORCID

Top concepts

Publications per year

1990–2024

30

Publications

30

Lung Adjuvant Cisplatin Evaluation: A Pooled Analysis by the LACE Collaborative Group

Jean‐Pierre Pignon, Hélène Tribodet, Giorgio V. Scagliotti et al. · Journal of Clinical Oncology · 2008 · 2.6K citations · Full text

Systematic Pelvic Lymphadenectomy vs No Lymphadenectomy in Early-Stage Endometrial Carcinoma: Randomized Clinical Trial

Pierluigi Benedetti Panici, S. Basile, F. Maneschi et al. · JNCI Journal of the National Cancer Institute · 2008 · 1.5K citations · Full text

Adjuvant chemoradiotherapy versus radiotherapy alone for women with high-risk endometrial cancer (PORTEC-3): final results of an international, open-label, multicentre, randomised, phase 3 trial

Stephanie M. de Boer, Melanie Powell, Linda Mileshkin et al. · The Lancet Oncology · 2018 · 599 citations · Full text

Sequential adjuvant chemotherapy and radiotherapy in endometrial cancer – Results from two randomised studies

Thomas Högberg, Mauro Signorelli, Carlos Oliveira et al. · European Journal of Cancer · 2010 · 448 citations · Full text

, , +6

Adjuvant chemoradiotherapy versus radiotherapy alone in women with high-risk endometrial cancer (PORTEC-3): patterns of recurrence and post-hoc survival analysis of a randomised phase 3 trial

Stephanie M. de Boer, Melanie Powell, Linda Mileshkin et al. · The Lancet Oncology · 2019 · 432 citations · Full text

Rows per page

1–5 of 30